Medicare is a government-funded program that gives healthcare coverage to people 65 or older.

People under 65 may be eligible for Medicare if they have:

  • Certain disabilities
  • End-stage renal disease (ESRD)
  • Amyotrophic Lateral Sclerosis (ALS), also called Lou Gehrig’s disease

There are 4 parts of Medicare: A, B, C, and D.

Medicare can be confusing. In this video we break down the different parts of Medicare, what they are for, and what you need to know.


Part A

Hospital Insurance

Inpatient care in hospitals and skilled nursing facilities; hospice care, and some home health care

Part B

Medical Insurance

Doctor visits and other outpatient services; medications given by a healthcare provider

Part C

Medicare Advantage

Part A and Part B offered by private health plans; most plans include prescription drug coverage

Part D

Prescription drug coverage

Helps cover the cost of prescription medications and some recommended vaccines

While Medicare covers many healthcare needs, it may not cover all healthcare costs for everyone. You may have to pay a monthly premium for Medicare and a co-pay, co-insurance, or deductible.

Janssen CarePath can help you learn how Medicare may cover your Janssen medications. We can also give you information on cost support.

Medicare Resource Guide

Medicare Resource Guide (en español)

Learn about the different parts of Medicare. Also see what it may cover, including medications.


  • Minimize
  • Expand
  • Full Screen
  • Return to Website

What is VELETRI®?

VELETRI® is a prescription medicine that is given intravenously (in a vein). It is used to treat adults with certain kinds of severe pulmonary arterial hypertension (PAH) (WHO Group 1), a condition in which blood pressure is too high in the blood vessels between the heart and the lungs. VELETRI® may improve your ability to exercise as measured by how far you can walk in 6 minutes (6-minute walk test).

Studies showing VELETRI® is effective included mainly patients with NYHA Functional Class III-IV PAH. In these patients, PAH was caused by unidentified or hereditary factors or connective tissue disease.


Who should not take VELETRI®?

VELETRI® should not be used if you have heart failure due to severe left heart disease, if you develop fluid in the lungs (pulmonary edema) when starting therapy, or if you are allergic to epoprostenol.

Some medications may interact with VELETRI®. Please talk to your doctor about all of your medications.

What is the most important information I should know about?

It is important to use VELETRI® as directed by your doctor. VELETRI® should be used only with Sterile Water for Injection, USP, or Sodium Chloride 0.9% Injection, USP. Do not mix VELETRI® with other intravenous medications. Each vial is for single use only; discard any unused medication. Use at room temperature (77°F/25°C). Do not expose VELETRI® to direct sunlight.

When you take epoprostenol for the first time, you must be in a setting (hospital or clinic) where you can be monitored for any serious side effects or in case of emergency. Your blood pressure and heart rate should also be monitored with any dose changes. If you are taking VELETRI®, your doctor may prescribe another kind of medicine used to prevent blood clots. It is the use of these medications concomitantly (in combination) with VELETRI® that may potentially cause an increase in the risk of bleeding.

Sudden and dramatic changes in dose may lead to unstable blood pressure, a return of pulmonary hypertension symptoms, or fatal low blood pressure (hypotension). Do not stop using VELETRI® without first talking to your doctor.

To reduce the risk of infection in the bloodstream, it is important to know how to properly care for the catheter and infusion pump.

What are the possible side effects of VELETRI®?

You may have side effects at the start of treatment or with dose increases. The most common side effects seen in at least 1% of patients were:

  • flushing
  • headache
  • nausea/vomiting
  • low blood pressure
  • anxiety/nervousness
  • chest pain
  • dizziness
  • slow heartbeat
  • abdominal pain
  • pain in the muscles and/or ligaments and bones
  • shortness of breath
  • back pain
  • sweating
  • upset stomach
  • numbness/increased sensitivity
  • fast heartbeat

The most common side effects in patients with PAH due to unidentified or hereditary factors with at least 10% difference between the group that received epoprostenol and the group that received conventional therapy alone were:

  • flu-like symptoms
  • fast heartbeat
  • flushing
  • diarrhea
  • nausea/vomiting
  • jaw pain
  • pain in the muscles and/or ligaments and bones
  • anxiety/nervousness
  • dizziness
  • headache
  • numbness/increased sensitivity/tingling

The most common side effects in patients with PAH due to connective tissue disease with at least 10% difference between the group that received epoprostenol and the group that received conventional therapy alone were:

  • flushing
  • low blood pressure
  • lack of appetite
  • nausea/vomiting
  • diarrhea
  • jaw pain
  • neck/joint pain
  • headache
  • skin ulcer
  • rash

Talk to your doctor if you have any side effect that bothers you or that does not go away. These are not all the possible side effects of VELETRI®. For more information, ask your doctor or pharmacist.

Call your healthcare provider for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

Please see full Prescribing Information for VELETRI® and discuss any questions you have with your doctor.